Roth Capital Downgrades Cypress Bioscience (CYPB) to Neutral
Tweet Send to a FriendGet Alerts CYPB Hot Sheet
Price: $6.50 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade CYPB Now!
Roth Capital downgraded Cypress Bioscience (NASDAQ: CYPB) from Buy to Neutral. PT $6.50.
For more ratings news on Cypress Bioscience click here and for the rating history of Cypress Bioscience click here.
Shares of Cypress Bioscience closed at $6.45 yesterday, with a 52 week range of $2.06-$6.84.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Cypress Bioscience click here and for the rating history of Cypress Bioscience click here.
Shares of Cypress Bioscience closed at $6.45 yesterday, with a 52 week range of $2.06-$6.84.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Goldman Sachs Downgrades Aixtron (AIXG) to Neutral
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
